g 25671 has been researched along with uric acid in 1 studies
*Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. [MeSH]
*Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BRODIE, BB; BURNS, JJ; GUTMAN, AB; PEREL, JM; RITTERBAND, A; YU, TF | 1 |
1 other study(ies) available for g 25671 and uric acid
| Article | Year |
|---|---|
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671.
Topics: Analgesics; Phenylbutazone; Safrole; Sulfinpyrazone; Sulfoxides; Uric Acid; Uricosuric Agents | 1957 |